|
gptkbp:instanceOf
|
gptkb:disease
|
|
gptkbp:affectsOrgan
|
liver
|
|
gptkbp:cause
|
liver cancer
cirrhosis
chronic hepatitis
|
|
gptkbp:causedBy
|
gptkb:Hepatitis_B_virus
|
|
gptkbp:complication
|
gptkb:hepatic_encephalopathy
liver failure
hepatocellular carcinoma
portal hypertension
ascites
|
|
gptkbp:diagnosedBy
|
gptkb:blood_test
|
|
gptkbp:firstDescribed
|
1965
|
|
gptkbp:hasGlobalPrevalence
|
over 250 million chronic cases
|
|
gptkbp:hasVaccineEfficacy
|
over 95%
|
|
gptkbp:hasVaccineSchedule
|
birth, 1 month, 6 months
|
|
gptkbp:hasVaccineType
|
plasma-derived vaccine
recombinant vaccine
|
|
gptkbp:ICD-10_code
|
gptkb:B18.0
B16
B18.1
|
|
gptkbp:isNotifiableDisease
|
true
|
|
gptkbp:MeSH_ID
|
D006509
|
|
gptkbp:mortalityRate
|
about 820,000 deaths per year (2022)
|
|
gptkbp:OMIM
|
610424
|
|
gptkbp:prevention
|
gptkb:Hepatitis_B_vaccine
gptkb:vaccine
safe injection practices
screening blood products
safe sex
|
|
gptkbp:riskFactor
|
mother-to-child transmission
sharing needles
blood transfusion
unprotected sex
|
|
gptkbp:symptom
|
nausea
vomiting
abdominal pain
fatigue
jaundice
loss of appetite
dark urine
asymptomatic in some cases
|
|
gptkbp:transmission
|
blood
sexual contact
perinatal
|
|
gptkbp:treatment
|
gptkb:antiviral_drug
gptkb:insulin
gptkb:lamivudine
gptkb:adefovir
gptkb:entecavir
tenofovir
pegylated interferon
|
|
gptkbp:bfsParent
|
gptkb:Gilead
|
|
gptkbp:bfsLayer
|
6
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Hepatitis B
|